Premium
Autoreactive T‐cell receptor (V β /D/J β ) sequences in diabetes are homologous to insulin, glucagon, the insulin receptor, and the glucagon receptor
Author(s) -
RootBernstein Robert
Publication year - 2008
Publication title -
journal of molecular recognition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.401
H-Index - 79
eISSN - 1099-1352
pISSN - 0952-3499
DOI - 10.1002/jmr.930
Subject(s) - glucagon receptor , t cell receptor , glucagon , receptor , insulin , biology , autoimmunity , glucagon like peptide 1 receptor , insulin receptor , endocrinology , diabetes mellitus , type 1 diabetes , medicine , immunology , microbiology and biotechnology , immune system , t cell , insulin resistance , genetics , agonist
The hypervariable (V β /D/J β ) regions of T‐cell receptors (TCR) have been sequenced in a variety of autoimmune diseases by various investigators. An analysis of some of these sequences shows that TCR from both human diabetics and NOD mice mimic insulin, glucagon, the insulin receptor, and the glucagon receptor. Such similarities are not found in the TCR produced in other human autoimmune diseases. These data may explain how insulin, glucagon, and their receptors are targets of autoimmunity in diabetes and also suggest that TCR mimicking insulin and its receptor may be targets of anti‐insulin autoantibodies. Such intra‐systemic mimicry of self‐proteins also raises complex questions about how “self” and “nonself” are regulated during TCR production, especially in light of the complementarity of insulin for its receptor and glucagon for its receptor. The data presented here suggest that some TCR may be complementary to other TCR in autoimmune diseases, a possibility that is experimentally testable. Such complementarity, if it exists, could either serve to down‐regulate the clones bearing such TCR or, alternatively, trigger an intra‐immune system civil war between them. Copyright © 2008 John Wiley & Sons, Ltd.